#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12856	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2215	577.9	0	.	n	.	0	A69G	SNP	69	69	A	368	368	G	738	G	694	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12856	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2215	577.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1749	1749	T	695	T	637	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12856	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2215	577.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1483	1483	C	776	C,T	731,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	653.5	0	.	n	.	0	T695C	SNP	695	695	T	1087	1087	C	706	C,T	668,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	653.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2363	2363	C	753	C	696	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	653.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2437	2437	A	744	A	703	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23264	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	653.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2989	2989	C	661	C,G	629,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1790	folP	855	855	100.0	folP.l15.c4.ctg.1	1577	113.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1093	1095	AGC	186;184;184	A;G;C	173;169;170	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5034	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3315	151.2	1	SNP	p	S91F	1	.	.	271	273	TTC	587	589	TTC	157;157;161	T;T;C	150;148;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5034	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3315	151.2	1	SNP	p	G95N	0	.	.	283	285	GGC	599	601	GGC	158;157;158	G;G;C	153;151;150	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5034	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3315	151.2	1	SNP	p	D95G	1	.	.	283	285	GGC	599	601	GGC	158;157;158	G;G;C	153;151;150	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1554	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1275	120.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	585	587	AAT	200;198;197	A,G;A;T	188,1;188;187	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1554	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1275	120.6	1	SNP	p	G45D	0	.	.	133	135	GGC	483	485	GGC	184;183;184	G;G;C	172;168;170	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	762	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	995	76.0	0	.	n	.	0	A197.	DEL	197	197	A	604	604	A	183	A	175	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	0	.	p	.	0	E91G	NONSYN	271	273	GAG	564	566	GGG	200;200;200	G;G;G	189;187;186	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	1	SNP	p	D86N	0	.	.	256	258	GAC	549	551	GAC	190;191;192	G;A;C	182;181;182	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	1	SNP	p	S87I	0	.	.	259	261	AGT	552	554	AGT	191;190;191	A;G;T	181;181;180	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	1	SNP	p	S87R	0	.	.	259	261	AGT	552	554	AGT	191;190;191	A;G;T	181;181;180	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	1	SNP	p	S87W	0	.	.	259	261	AGT	552	554	AGT	191;190;191	A;G;T	181;181;180	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4550	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2849	159.2	1	SNP	p	S88P	0	.	.	262	264	TCC	555	557	TCC	192;191;191	T;C;C	180;180;181	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3944	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2570	152.6	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1509	1511	CAC	176;177;176	C;A;C	163;162;163	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3944	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2570	152.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1458	1460	GGC	168;165;162	G;G;C	162;160;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1223	1225	GCA	191;195;196	G;C;A	171;171;175	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1226	1228	ATC	196;195;192	A;T;C	178;173;170	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1238	1240	GTG	195;196;197	G;T;G	177;176;179	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1238	1240	GTG	195;196;197	G;T;G	177;176;179	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1742	1744	ACC	175;176;174	A;C;C	158;163;160	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1796	1798	ACG	172;170;168	A;C;G	138;138;140	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1796	1798	ACG	172;170;168	A;C;G	138;138;140	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1919	1921	GGC	154;152;154	G;G;C	146;142;146	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1928	1930	GGC	155;159;160	G;G;C	144;145;146	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	3560	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2283	154.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1946	1948	CTG	144;145;141	C,G;T;G	111,1;111;107	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5102	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3215	158.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1617	1619	CCG	195;194;195	C;C;G	175;180;174	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2092	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1921	108.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	654	654	C	152	C	140	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	T26A	NONSYN	76	78	ACC	425	427	GCC	203;203;199	G,A;C;C	191,1;190;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	461	463	GAA	201;198;199	G;A;A	186;183;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	N124S	NONSYN	370	372	AAT	719	721	AGT	203;205;205	A;G;T	190;189;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	749	751	GAT	211;213;218	G;A;T	202;203;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	872	874	TCA	198;201;202	T;C;A	182;186;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1001	1003	GTC	178;177;174	G;T;C	166;166;164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1013	1015	TCT	171;173;176	T;C;T	162;165;166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	0	.	p	.	0	E328_G329del	DEL	982	982	G	1330	1330	A	178	A	165	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	1	SNP	p	G120K	1	.	.	358	360	AAG	707	709	AAG	202;204;201	A;A;G	188;190;187	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	1	SNP	p	A121D	1	.	.	361	363	GAC	710	712	GAC	200;204;205	G;A;C	188;188;190	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2328	porB1b	1047	1047	97.99	porB1b.l15.c17.ctg.1	1524	151.8	1	SNP	p	D121N	0	.	.	361	363	GAC	710	712	GAC	200;204;205	G;A;C	188;188;190	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9084	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4990	181.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2079	2081	CAT	197;196;195	C;A;T	185;182;180	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1024	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	953	106.2	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	206;206;205	A;T;G	195;195;192	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
